# Study in Adult Ph-positive ALL

> **NCT04688983** · PHASE2 · UNKNOWN · sponsor: **Cardiff University** · enrollment: 180 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia, Adult

## Interventions

- **DRUG:** Ponatinib
- **DRUG:** Blinatumomab
- **DRUG:** Imatinib

## Key facts

- **NCT ID:** NCT04688983
- **Lead sponsor:** Cardiff University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01
- **Primary completion:** 2024-01
- **Final completion:** 2026-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2020-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04688983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04688983, "Study in Adult Ph-positive ALL". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT04688983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*